Ying Huang is an experienced professional in the field of biomanufacturing and biologics process development, currently serving as Executive Director of CMC Management at WuXi Biologics, following a role as Senior Director in the same department. Prior experience includes positions such as Sr. Principal Scientist and Group Leader for Biologics Process Development at Merck, Lab Head of Preclinical R&D at GSK Vaccines, Director of Process Development & Manufacturing at KBI Biopharma, and Sr. Scientist at the Vaccine Research Center of the National Institutes of Health. Ying Huang possesses a strong background in vaccine research and development, contributing to advancements in the biopharmaceutical industry.